Latest Breaking News On - Sarah sutton kevin murphy - Page 1 : comparemela.com

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

La jollaUnited statesSan diegoRichard waldonSarah sutton kevin murphyDavid basileRachel lehenyInstitute for biomedical researchIndiana universityExchange commissionDrug administrationCalcimedica incPrnewswire calcimedica incSinai medical centerInternational acute kidney injuryDigestive disease week

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

Full target enrollment of 216 patients achieved

United statesRachel lehenySarah sutton kevin murphyInstitute for biomedical researchPrnewswire calcimedica incCalcimedica incChief executive officerTorrey pines therapeuticsBiomedical researchPrivate securities litigation reform actAnnual reportMedica contact

Calcimedica Reports 2023 Financial Results And Provides Clinical & Corporate Updates

Calcimedica Reports 2023 Financial Results And Provides Clinical & Corporate Updates
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoLa jollaRachel lehenySarah sutton kevin murphyJude children research hospitalAmerican society of hematology meeting expositionInternational acute kidney injuryInstitute for biomedical researchExchange commissionDrug administrationGraybug vision incPrnewswire calcimedica incInvestigational new drugChief executive officerPreclinical updates

CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

/PRNewswire/ CalciMedica Inc. (CalciMedica or the Company) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium.

United statesLa jollaSan diegoSarah sutton kevin murphyDavidp basileIndiana universityCompany nasdaqInstitute for biomedical researchPrnewswire calcimedica incCalcimedica incTranslational researchInternational acute kidney injuryContinuous renal replacement therapy conferenceOral sessionTorrey pines therapeuticsBiomedical research

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

LA JOLLA, Calif., Feb. 7, 2024 /PRNewswire/ CalciMedica Inc. , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium channel inhibition.

Sarah sutton kevin murphyRachel lehenyCalcimedica incHealthcare life sciences conference onPrnewswire calcimedica incInstitute for biomedical researchChief executive officerAnnual healthcare life sciences conferenceTorrey pines therapeuticsBiomedical researchMedica contact